You are here:

Home
NICE Guidance
Conditions and diseases
Blood and immune system conditions
Blood and bone marrow cancers

Decitabine for the treatment of acute myeloid leukaemia (terminated appraisal)

Technology appraisal
Reference number: TA270
Published: 12 December 2012

Guidance
Tools and resources
History

Tools and resources

Tools to help you put the guidance into practice.

Guidance into practice

About the Into practice guide
Practical steps to improving the quality of care and services using NICE guidance